Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,634 total articles

National Fuel Releases its 2025 Corporate Responsibility Report

National Fuel Releases its 2025 Corporate Responsibility Report

National Fuel Gas Company has released its 2025 Corporate Responsibility Report detailing progress in sustainability, safety, methane emissions reduction, and community support. The report underscores the company's commitment to responsible business practices, significant methane intensity reductions across its operations, and ongoing efforts to su…

Dogfish Head Announces Lineup of Fall-Favorite Beverages

Dogfish Head Announces Lineup of Fall-Favorite Beverages

Dogfish Head Craft Brewery, a brand under Boston Beer Company, announced its lineup of fall seasonal beverages including the returning fan-favorite Punkin Ale, a new variety pack featuring exclusive brews, a new iteration of World Wide Stout called Xocolatl, and the debut of Punkin Liqueur. These offerings aim to capture the autumn market with inno…

Indonesia Energy to Present at H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026

Indonesia Energy to Present at H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026

Indonesia Energy Corporation Limited announced that President Frank Ingriselli will present an update on the company’s drilling and production activities at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover recent developments such as the completion of drilling at the K-29 well and plans for new drilling at t…

Cullinan Therapeutics to Host Virtual Analyst and Investor Event to Showcase Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer

Cullinan Therapeutics to Host Virtual Analyst and Investor Event to Showcase Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer

Cullinan Therapeutics announced that its Phase 3 REZILIENT3 trial of zipalertinib plus chemotherapy for first-line treatment of EGFR exon 20 insertion mutation-positive non-small cell lung cancer (NSCLC) met its primary endpoint of progression-free survival at planned interim analysis. The results will be presented in a Presidential Symposium at th…

Alpha Compute Secures $47 Million in Seller Financing for Planned 200MW Pennsylvania AI Data Center Campus

Alpha Compute Secures $47 Million in Seller Financing for Planned 200MW Pennsylvania AI Data Center Campus

Alpha Compute Corp. (Nasdaq: ALP) announced a $47 million seller-financed property acquisition structuring for its planned 200 MW AI data center campus in Pennsylvania. The financing reduces upfront cash needs, aligns sellers with project success, and supports a greenfield development with potential 1 GW expansion powered by on-site Marcellus natur…

FingerMotion Signs Binding Commitment to Acquire Rights and Permitting for 9.9 MW Powered Land Site in County of Newell, Alberta

FingerMotion Signs Binding Commitment to Acquire Rights and Permitting for 9.9 MW Powered Land Site in County of Newell, Alberta

FingerMotion, Inc. has signed a binding memorandum to acquire land rights and permitting for a 9.9 MW behind-the-meter natural gas power generation and compute site in Alberta's County of Newell. This marks the first acquisition in their planned Brooks Campus Zone, targeting AI and HPC markets by leveraging localized power generation that avoids gr…

Figure Partners with Sierra to Supercharge Loan Officers with AI Agents That Turn Abandoned Home Equity Applications into Funded Loans

Figure Partners with Sierra to Supercharge Loan Officers with AI Agents That Turn Abandoned Home Equity Applications into Funded Loans

Figure Technology Solutions partners with Sierra to integrate Sierra's Horizon conversational AI platform into Figure's Loan Origination System. This collaboration automates follow-up with stalled home equity loan applicants, addressing the industry's high abandonment rates. Early results show a 143% increase in funded loans when combining AI agent…

NCT Issues Official Statement to Shareholders Reinforcing Long-Term Commitment, Compliance and Transparency

NCT Issues Official Statement to Shareholders Reinforcing Long-Term Commitment, Compliance and Transparency

Intercont (Cayman) Limited (NASDAQ: NCT) issued a statement reaffirming its dedication to sustainable business development, regulatory compliance, and transparent governance. The company emphasizes its focus on long-term value creation and commitment to meeting Nasdaq listing standards amidst market uncertainties, assuring shareholders of continued…

Nutanix Recognized as a Leader in the Gartner® Distributed Hybrid Infrastructure Magic Quadrant™

Nutanix Recognized as a Leader in the Gartner® Distributed Hybrid Infrastructure Magic Quadrant™

Nutanix has been recognized as a Leader in Gartner's 2026 Magic Quadrant for Distributed Hybrid Infrastructure due to its strong execution and comprehensive vision. The company’s Nutanix Cloud Platform supports AI workloads and diverse hybrid environments with enhanced Kubernetes capabilities, agentic AI features, and broadened infrastructure flexi…

Vishay Intertechnology XClampR® Bidirectional Flat Clamping TVS in DO-218AC Package Deliver Low Clamping Voltage, High Power Density

Vishay Intertechnology XClampR® Bidirectional Flat Clamping TVS in DO-218AC Package Deliver Low Clamping Voltage, High Power Density

Vishay Intertechnology introduced the XFD11KxxCA series of bidirectional XClampR flat clamping transient voltage suppressors (TVS) in the DO-218AC surface-mount package. These devices offer industry-leading peak pulse power dissipation up to 11 kW with low clamping ratios and improved performance metrics, targeting automotive, industrial, and telec…

BOS to Release Third Quarter 2026 Results on November 30, 2026

BOS to Release Third Quarter 2026 Results on November 30, 2026

BOS Better Online Solutions Ltd., an integrator of supply chain technologies for aerospace, defense, industrial, and retail sectors, announced that it will release its third quarter 2026 financial results before the market opens on November 30, 2026. The company will hold a video conference call at 8:30 a.m. Eastern Time the same day. BOS operates …

IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001

IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001

IMUNON, Inc. has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute’s Cancer Therapy Evaluation Program (CTEP) to expand clinical and non-clinical development of its DNA-based IL-12 immunotherapy, IMNN-001. The collaboration aims to evaluate IMNN-001 in new solid tumor types and combination trea…

Gix Internet Launches New Corporate Website Presenting Its Vision for One Intelligent Management Layer for Robots, People and Autonomous Systems

Gix Internet Launches New Corporate Website Presenting Its Vision for One Intelligent Management Layer for Robots, People and Autonomous Systems

Gix Internet Ltd., dual-listed on Nasdaq and the Tel Aviv Stock Exchange, launched a new corporate website presenting its AI-powered management and orchestration software layer coordinating autonomous robots and human teams in hospital logistics. Through its subsidiary Deliverz.ai, Gix has successfully deployed this technology at Sheba Medical Cent…

Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment

Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment

Outlook Therapeutics CEO Bob Jahr highlighted the FDA approval of LYTENAVA™, the only ophthalmic formulation of bevacizumab approved for treating wet age-related macular degeneration (AMD) in the U.S. The company plans a commercial launch by the end of 2026, targeting over $500 million in annual U.S. sales by 2030 by shifting off-label use to this …

Codere Online Becomes Official Betting Partner of the NFL in Mexico

Codere Online Becomes Official Betting Partner of the NFL in Mexico

Codere Online has announced a multi-year agreement to become the official betting partner of the NFL in Mexico. This landmark deal positions Codere alongside one of the world's most recognized sports brands, enhancing its premium brand positioning and deepening engagement with the passionate NFL fanbase in Mexico. The partnership includes sponsorsh…